BA-2702 | CAS#713-05-3 | biochemical

MedKoo Cat#: 145699 | Name: BA-2702

Description:

WARNING: This product is for research use only, not for human or veterinary use.

BA-2702 is a chemical compound that has been investigated for its potential therapeutic properties, particularly in the area of cancer research. It is a selective inhibitor of certain enzymes or pathways that are involved in the growth and spread of cancer cells.

Chemical Structure

BA-2702

CAS#713-05-3

Theoretical Analysis

MedKoo Cat#: 145699

Name: BA-2702

CAS#: 713-05-3

Chemical Formula: C10H12N2O2

Exact Mass: 192.0900

Molecular Weight: 192.22

Elemental Analysis: C, 62.49; H, 6.29; N, 14.57; O, 16.65

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

BA-2702; BA2702; BA 2702;

IUPAC/Chemical Name

N-methyl-4-oxo-4-(pyridin-3-yl)butanamide

InChi Key

WOOSCPWOYYLIHS-UHFFFAOYSA-N

InChi Code

1S/C10H12N2O2/c1-11-10(14)5-4-9(13)8-3-2-6-12-7-8/h2-3,6-7H,4-5H2,1H3,(H,11,14)

SMILES Code

CNC(=O)CCC(=O)C1=CC=CN=C1

Appearance

To be determined

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 192.22 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Vallabh SM, Mortberg MA, Allen SW, Kupferschmid AC, Kivisakk P, Hammerschlag BL, Bolling A, Trombetta BA, Devitte-McKee K, Ford AM, Sather LE, Duffy G, Rivera A, Gerber J, McManus AJ, Minikel EV, Arnold SE. Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion. Neurology. 2024 Jul 23;103(2):e209506. doi: 10.1212/WNL.0000000000209506. Epub 2024 Jun 19. PMID: 38896810; PMCID: PMC11226308. 2: Ardiansyah E, Avila-Pacheco J, Nhat LTH, Dian S, Vinh DN, Hai HT, Bullock K, Alisjahbana B, Netea MG, Estiasari R, Tram TTB, Donovan J, Heemskerk D, Chau TTH, Bang ND, Ganiem AR, Ruslami R, Koeken VACM, Hamers RL, Imran D, Maharani K, Kumar V, Clish CB, van Crevel R, Thwaites G, van Laarhoven A, Thuong NTT. Tryptophan metabolism determines outcome in tuberculous meningitis: a targeted metabolomic analysis. Elife. 2023 May 9;12:e85307. doi: 10.7554/eLife.85307. PMID: 37158692; PMCID: PMC10181821. 3: Chen M, Zhang X, Xiong Y, Xu G. Efficacy of low or heavy rituximab‑based protocols and comparison with seven regimens in idiopathic membranous nephropathy: a systematic review and network meta-analysis. Int Urol Nephrol. 2023 Mar;55(3):641-651. doi: 10.1007/s11255-022-03372-5. Epub 2022 Sep 25. PMID: 36161550. 4: Santos RPO, Nunes JA, Dias NG, Lisboa AS, Antunes VH, Pereira EJ, Barbosa SDN. Working conditions in primary health care in the COVID-19 pandemic: an overview of Brazil and Portugal. Cien Saude Colet. 2023 Oct;28(10):2979-2992. Portuguese, English. doi: 10.1590/1413-812320232810.10002023. Epub 2023 Jun 27. PMID: 37878939. 5: Abbruzzetti S, Barker AJ, Villar I, Pérez-Rontomé C, Bruno S, Cerullo G, Viappiani C, Becana M. Unusually Fast bis-Histidyl Coordination in a Plant Hemoglobin. Int J Mol Sci. 2021 Mar 8;22(5):2740. doi: 10.3390/ijms22052740. PMID: 33800498; PMCID: PMC7962945. 6: Amrute JM, Lee PC, Eres I, Lee CJM, Bredemeyer A, Sheth MU, Yamawaki T, Gurung R, Anene-Nzelu C, Qiu WL, Kundu S, Li DY, Ramste M, Lu D, Tan A, Kang CJ, Wagoner RE, Alisio A, Cheng P, Zhao Q, Miller CL, Hall IM, Gupta RM, Hsu YH, Haldar SM, Lavine KJ, Jackson S, Andersson R, Engreitz JM, Foo RS, Li CM, Ason B, Quertermous T, Stitziel NO. Single cell variant to enhancer to gene map for coronary artery disease. medRxiv [Preprint]. 2024 Nov 13:2024.11.13.24317257. doi: 10.1101/2024.11.13.24317257. PMID: 39606421; PMCID: PMC11601770. 7: Mohanty SK, Donnelly B, Temple H, Mowery S, Poling HM, Meller J, Malik A, McNeal M, Tiao G. Rhesus rotavirus receptor-binding site affects high mobility group box 1 release, altering the pathogenesis of experimental biliary atresia. Hepatol Commun. 2022 Oct;6(10):2702-2714. doi: 10.1002/hep4.2024. Epub 2022 Jul 22. PMID: 35866580; PMCID: PMC9512450. 8: Vishwanath S, Carnell GW, Billmeier M, Ohlendorf L, Neckermann P, Asbach B, George C, Sans MS, Chan A, Olivier J, Nadesalingam A, Einhauser S, Temperton N, Cantoni D, Grove J, Jordan I, Sandig V, Tonks P, Geiger J, Dohmen C, Mummert V, Samuel AR, Plank C, Kinsley R, Wagner R, Heeney JL. Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants. NPJ Vaccines. 2024 Sep 9;9(1):164. doi: 10.1038/s41541-024-00950-9. PMID: 39251608; PMCID: PMC11384739. 9: Waller E, Sutton P, Rahman S, Allen J, Saxton J, Aziz O. Prehabilitation with wearables versus standard of care before major abdominal cancer surgery: a randomised controlled pilot study (trial registration: NCT04047524). Surg Endosc. 2022 Feb;36(2):1008-1017. doi: 10.1007/s00464-021-08365-6. Epub 2021 Mar 15. PMID: 33723969; PMCID: PMC8758615. 10: Domenyuk V, Gatalica Z, Santhanam R, Wei X, Stark A, Kennedy P, Toussaint B, Levenberg S, Wang J, Xiao N, Greil R, Rinnerthaler G, Gampenrieder SP, Heimberger AB, Berry DA, Barker A, Quackenbush J, Marshall JL, Poste G, Vacirca JL, Vidal GA, Schwartzberg LS, Halbert DD, Voss A, Magee D, Miglarese MR, Famulok M, Mayer G, Spetzler D. Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes. Nat Commun. 2018 Mar 23;9(1):1219. doi: 10.1038/s41467-018-03631-z. PMID: 29572535; PMCID: PMC5865185. 11: Habermaass V, Bartoli F, Gori E, Dini R, Cogozzo A, Puccinelli C, Pierini A, Marchetti V. Fecal Bile Acids in Canine Chronic Liver Disease: Results from 46 Dogs. Animals (Basel). 2024 Oct 22;14(21):3051. doi: 10.3390/ani14213051. PMID: 39518774; PMCID: PMC11545594. 12: Bourelle SA, Shivanna R, Camargo FVA, Ghosh S, Gillett AJ, Senanayak SP, Feldmann S, Eyre L, Ashoka A, van de Goor TWJ, Abolins H, Winkler T, Cerullo G, Friend RH, Deschler F. How Exciton Interactions Control Spin-Depolarization in Layered Hybrid Perovskites. Nano Lett. 2020 Aug 12;20(8):5678-5685. doi: 10.1021/acs.nanolett.0c00867. Epub 2020 Jul 8. PMID: 32574069. 13: Jabbar AAJ, Alamri ZZ, Abdulla MA, Salehen NA, Ibrahim IAA, Hassan RR, Almaimani G, Bamagous GA, Almaimani RA, Almasmoum HA, Ghaith MM, Farrash WF, Almutawif YA. Boric Acid (Boron) Attenuates AOM-Induced Colorectal Cancer in Rats by Augmentation of Apoptotic and Antioxidant Mechanisms. Biol Trace Elem Res. 2024 Jun;202(6):2702-2719. doi: 10.1007/s12011-023-03864-0. Epub 2023 Sep 29. PMID: 37770673. 14: Zuo C, Xu G. Efficacy and safety of mineralocorticoid receptor antagonists with ACEI/ARB treatment for diabetic nephropathy: A meta-analysis. Int J Clin Pract. 2019 Aug 29:e13413. doi: 10.1111/ijcp.13413. Epub ahead of print. PMID: 31464019. 15: Santos TF, Santana LK, Santos AC, Silva GS, Romano CC, Dias JC, Rezende RP. Lactic acid bacteria dynamics during spontaneous fermentation of cocoa beans verified by culture-independent denaturing gradient gel electrophoresis. Genet Mol Res. 2011 Nov 4;10(4):2702-9. doi: 10.4238/2011.November.4.3. PMID: 22095596. 16: Zimmermann T, von der Au M, Reese A, Klein O, Hildebrandt L, Pröfrock D. Substituting HF by HBF4- an optimized digestion method for multi- elemental sediment analysis via ICP-MS/MS. Anal Methods. 2020 Aug 14;12(30):3778-3787. doi: 10.1039/d0ay01049a. Epub 2020 Jul 24. PMID: 32706011. 17: Gordon AJ, Conigliaro J, Maisto SA, McNeil M, Kraemer KL, Kelley ME. Comparison of consumption effects of brief interventions for hazardous drinking elderly. Subst Use Misuse. 2003 Jun;38(8):1017-35. doi: 10.1081/ja-120017649. PMID: 12901447. 18: Honsawek S, Chaiwatanarat T, Vejchapipat P, Chongsrisawat V, Thawornsuk N, Poovorawan Y. Relationships between OPG, RANKL, bone metabolism, and bone mineral density in biliary atresia. Pediatr Surg Int. 2009 Mar;25(3):261-7. doi: 10.1007/s00383-009-2325-y. Epub 2009 Jan 29. PMID: 19184056. 19: Claverie F, Malherbe J, Bier N, Molloy JL, Long SE. Putting a spin on LA- ICP-MS analysis combined to isotope dilution. Anal Bioanal Chem. 2013 Mar;405(7):2289-99. doi: 10.1007/s00216-012-6645-8. Epub 2013 Jan 11. PMID: 23307123. 20: Galan AM, Reverter JC, Bozzo J, Hernandez MR, Escolar G, Aznar-Salatti J. Assessment of potential thrombogenicity of coagulation factor IX concentrates in an in vitro model of human thrombogenesis. Thromb Res. 1999 Dec 1;96(5):383-9. doi: 10.1016/s0049-3848(99)00134-6. PMID: 10605953.